19-13298941-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The NM_001127222.2(CACNA1A):c.2692G>A(p.Gly898Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00011 in 1,592,736 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001127222.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.2692G>A | p.Gly898Ser | missense_variant | Exon 19 of 47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.2704G>A | p.Gly902Ser | missense_variant | Exon 19 of 48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.2698G>A | p.Gly900Ser | missense_variant | Exon 19 of 47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.2695G>A | p.Gly899Ser | missense_variant | Exon 19 of 47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.2695G>A | p.Gly899Ser | missense_variant | Exon 19 of 47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.2695G>A | p.Gly899Ser | missense_variant | Exon 19 of 46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.2554G>A | p.Gly852Ser | missense_variant | Exon 18 of 46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.2695G>A | p.Gly899Ser | missense_variant | Exon 19 of 47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.2704G>A | p.Gly902Ser | missense_variant | Exon 19 of 48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.2695G>A | p.Gly899Ser | missense_variant | Exon 19 of 48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.2698G>A | p.Gly900Ser | missense_variant | Exon 19 of 47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.2695G>A | p.Gly899Ser | missense_variant | Exon 19 of 47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.2695G>A | p.Gly899Ser | missense_variant | Exon 19 of 47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.2695G>A | p.Gly899Ser | missense_variant | Exon 19 of 46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000372 AC: 8AN: 214956Hom.: 0 AF XY: 0.0000418 AC XY: 5AN XY: 119734
GnomAD4 exome AF: 0.000118 AC: 170AN: 1440550Hom.: 0 Cov.: 32 AF XY: 0.000120 AC XY: 86AN XY: 716688
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74340
ClinVar
Submissions by phenotype
Migraine, familial hemiplegic, 1 Uncertain:1
_x000D_ Criteria applied: PP3, BS1 -
not specified Benign:1
Variant summary: CACNA1A c.2695G>A (p.Gly899Ser) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was detected at a frequency of 0.00011 in 1592736 control chromosomes, suggesting the variant could be benign. To our knowledge, no occurrence of c.2695G>A in individuals affected with Epileptic Encephalopathy, Early Infantile, 42 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 572781). Based on the evidence outlined above, the variant was classified as likely benign. -
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
- -
CACNA1A-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at